Eugit Therapeutics

Enabling Tissue Targeting of Therapies

San Carlos, United States · Founded 2022 · $775K raised

Employees
1–10
Founded
2022
Total Funding
$775K
Last Round
$275K GrantAug 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).

Summary

Eugit Therapeutics is a Biotech company based in San Carlos, United States, founded in 2022. It has raised $775K in total across 2 rounds, most recently a $275K Grant round in Aug 2024. Investors include US National Science Foundation and Y Combinator.

Funding History

GrantAug 2024
$275K

Sign up to see all 2 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eugit Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/eugit"><img src="https://indexed.vc/api/badge/company/eugit" alt="Eugit Therapeutics on Indexed.vc" width="260" height="76" /></a>